Funding for this research was provided by:
Received: 20 March 2018
Accepted: 7 February 2019
First Online: 14 February 2019
Ethics approval and consent to participate
: The research aspects of MOPHAR were approved by the independent medical ethics committee (RTPO 928, rTPO Leeuwarden, The Netherlands). All participants in MOPHAR research provide written informed consent for use of their data and withdrawal of an extra blood sample for research purposes. Patients that do not provide informed consent for MOPHAR research, will still receive somatic monitoring care from the MOPHAR monitoring program (but their data will not be used nor will an extra blood sample be withdrawn for research purposes).
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.